JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
RNA Research Solutions

RNA Research Solutions

M2010 4A3-SC8

Summary: 4A3-SC8 is a modular degradable dendrimer. It enables small RNAs to extend survival in an aggressive liver cancer model.

≥40.1 mg/mL
M2011 1,2-Dioleoyl-sn-glycero-3-phosphate, sodium salt

Summary: 1,2-Dioleoyl-sn-glycero-3-phosphate sodium salt (18:1 PA) is an anionic lipid that can be used to prepare liposomes, micelles and artificial membranes.

≥4.54 mg/mL
C1042 SM-102
4 Citation

insoluble in DMSO; ≥175.8 mg/mL
B8595 ALC-0315

Summary: ALC-0315 is an ionizable amino lipid that can be combined with other lipids to form lipid nanoparticles (LNP). LNP containing ALC-0315 can be utilized for the delivery of mRNA vaccines.

≥59.3 mg/mL
B8596 ALC-0159

Summary: ALC-0159 is a lipid excipient. ALC-0159-containing formulation have been used to develop lipid nanoparticles (LNPs) for the delivery of mRNA-based vaccines.

≥39.4 mg/mL
R1021 EZ Cap™ Renilla Luc mRNA

Summary: Renilla Luc mRNA with Cap 1 structure, providing higher transcription efficiency and enhanced stability.
R1022 EZ Cap™ Renilla Luc mRNA (5-moUTP)

Summary: Renilla Luc mRNA with Cap 1 structure, modified by 5-moUTP, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.
R1023 EZ Cap™ Human p53 mRNA

Summary: Human p53 mRNA with Cap 1 structure, providing higher transcription efficiency and enhanced stability.
R1024 EZ Cap™ Human p53 mRNA (ψUTP)

Summary: Human p53 mRNA with Cap 1 structure, modified by ψUTP, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.
R1025 EZ Cap™ Human PTEN mRNA
2 Citation

Summary: Human PTEN mRNA with Cap 1 structure, providing higher transcription efficiency and enhanced stability.